This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
The innate immune system detects pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) to signal infection and other types of danger to provide host defense against external and internal threats including cancer. Dr. Manik’s proposal addresses the fundamental question on how this process occurs through the proposed study on an important cytosolic protein known as TRIF. TRIF is part of the receptor signaling system from the so-called Toll-like receptors (TLRs). However, his preliminary studies started to suggest that it also acts as a sensor of nucleic acids inside cells. Constant oxidative stress in cancer cells leads to organ damage and the release of DNA/RNA. Therefore, DNA/RNA sensors are of great interest in understanding cancer and in cancer therapy. In this project, Dr. Manik aims to deepen our understanding of nucleic acid sensing role of TRIF in physiology and pathophysiology by adopting a multi-disciplinary approach. These studies will have strong impact in the general area of cancer and inflammation.
Boston Children’s Hospital | All Cancers | 2022 | Hao Wu, Ph.D.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).